CN103054981A - External traditional Chinese medicine for treating abdominal malignant tumours - Google Patents
External traditional Chinese medicine for treating abdominal malignant tumours Download PDFInfo
- Publication number
- CN103054981A CN103054981A CN201310036743XA CN201310036743A CN103054981A CN 103054981 A CN103054981 A CN 103054981A CN 201310036743X A CN201310036743X A CN 201310036743XA CN 201310036743 A CN201310036743 A CN 201310036743A CN 103054981 A CN103054981 A CN 103054981A
- Authority
- CN
- China
- Prior art keywords
- parts
- prepared
- radix
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention relates to an external traditional Chinese medicine for treating abdominal malignant tumours, which is prepared from the following medicinal materials in parts by weight: 10 parts of rhizoma corydalis, 21 parts of prepared semen strychni, 9 parts of asarum, 25 parts of Oldenlandia diffusa, 10 parts of Scutellaria baicalensis, 10 parts of elecampane, 10 parts of radix angelicae, 15 parts of the root of three-nerved spicebush, 10 parts of scorpio, 9 parts of borneol, 16 parts of prepared radix aconiti agrestis, 10 parts of wall gecko, 7 parts of centipede, 10 parts of prepared frankincense, 10 parts of prepared myrrh, 16 parts of Sculellaria barbata, 10 parts of prepared monkshood, and 15 parts of Chinese actinidia root. Clinical experiments prove that the external traditional Chinese medicine disclosed by the invention is capable of treating abdominal malignant tumours safely and effectively.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of external application Chinese medicine for the treatment of the abdominal cavity malignant tumor.
Background technology
Tumor (Tumor) be body under various carcinogenic factor effects, some cells of local organization lose normal regulation to its growth at gene level, cause its clonal abnormality hypertrophy and the abnormality that forms, have optimum and pernicious minute.As the term suggests the abdominal cavity malignant tumor is namely long in Intraabdominal malignant tumor.
At present mainly take operation and chemicotherapy as main, but curative effect is also undesirable, still lacks the effective medicine of generally recognized as safe for the treatment of abdominal cavity malignant tumor.
Summary of the invention
The present invention aims to provide a kind of external application Chinese medicine for the treatment of the abdominal cavity malignant tumor, by selecting suitable medical material and proportioning thereof, reaches the purpose of safe and effective healing abdominal cavity malignant tumor.
In order to achieve the above object, the present invention is by the following technical solutions:
A kind of external application Chinese medicine for the treatment of the abdominal cavity malignant tumor, it is characterized in that, be prepared from by the medical material of following weight proportion: 10 parts of Rhizoma Corydalis, 21 parts of Semen Strychni (processed)s, 9 parts of Herba Asaris, 25 parts of Herba Hedyotidis Diffusaes, 10 parts of Radix Scutellariaes, 10 parts of the Radix Aucklandiae, 10 parts of the Radixs Angelicae Dahuricae, 15 parts of the Radixs Linderae, 10 parts of Scorpios, 9 parts of Borneolum Syntheticums, 16 parts of Radix Aconiti Kusnezoffii Preparatas, 10 parts of Gekko Swinhonis, 7 parts of Scolopendras, 10 parts of Olibanum (processed)s, 10 parts of Myrrha (processed)s, 16 parts of Herba Scutellariae Barbataes, 10 parts of Radix Aconiti Preparatas, 15 parts of Radix Actinidiae Chinensis.
Below in conjunction with tcm theory beneficial effect of the present invention is described:
Semen Strychni (processed), Radix Aconiti Preparata, Radix Aconiti Kusnezoffii Preparata, Olibanum (processed) all are key medicines of pain relieving eliminating stagnation, mutual compatibility, the complementary multiplication of drug effect.Herba Hedyotidis Diffusae: return lung, liver, stomach warp, clearing away heat-damp and promoting diuresis, the cold unlikely stomach that hinders of the property of medicine, the anti-merit that the removing food stagnancy food is arranged.Herba Asari acrid in the mouth perfume (or spice) is altered. and can outer dispersing wind and cold. again can the internalization cold fluid-retention, the pain relieving of having one's ideas straightened out; A most important effect can enter exactly the moon and search heresy, wind and cold, phlegm retention search are separated and appears external.Rhizoma Corydalis is mainly used in all pains of stagnation of QI and blood and demonstrate,proves, and the loose temperature of suffering is logical, " stagnation of QI in the energy promoting the circulation of blood, stasis in the gas is so specially control up and down all pains of the whole body ".Radix Scutellariae heat clearing and damp drying, eliminating fire and detoxication; The Scorpio relieving spasm by subduing liver-wind, detoxicating and resolving stagnation of pathogens; Radix Aucklandiae circulation of qi promoting, in the accent, pain relieving can rise and can fall.Radix Angelicae Dahuricae cold expelling is sensible, wind-expelling pain-stopping, detumescence and apocenosis; Radix Linderae promoting the circulation of QI to relieve pain, warming kidney for dispelling cold.The Borneolum Syntheticum refreshment of having one's ideas straightened out, clearing away heat to alleviate pain.Gekko Swinhonis is salty, cold, slightly poisonous, removing obstruction for relieving pain, expelling wind for relieving convulsion.Scolopendra endogenous wind stopping spasmolytic, merit poison eliminating stagnation, removing obstruction in the collateral to relieve pain; Herba Scutellariae Barbatae: heat-clearing and toxic substances removing, blood stasis dispelling diuresis.More than all medicines different returning through, the different five tastes all arranged, compatibility really brings out the best in each other, and plays altogether the eliminating stagnation silt, alleviating pain and detumescence is except swollen merit.
Below in conjunction with clinical experiment data declaration beneficial effect of the present invention:
1, physical data
The inventor collects 150 routine abdominal cavity malignant tumor (as: transfer of oophoroma abdominal cavity, advanced liver cancer, advanced colorectal cancer, late gastric cancer, advanced pancreatic cancer) patients altogether between year March in October, 2009-2011.Age 42-65 year, course of disease 0.5-6.Be divided at random: treatment group 100 examples, blank group 50 examples.The data there was no significant differences such as two groups of ages, the state of an illness have comparability.
2, test method
2.1 the unguentum that treatment group external application the present invention makes according to specific embodiment 1, external application every day are once, keep more than 16 hours at every turn.One month course for the treatment of.
2.2 blank group external application placebo, external application every day is once kept more than 16 hours at every turn.One month course for the treatment of.
3, criterion of therapeutical effect and therapeutic outcome
3.1 criterion of therapeutical effect
Recovery from illness: clinical symptoms all disappears, and test chamber inspection tumor is obviously dwindled or disappeared.Take a turn for the better: clinical symptom relief, the lab testing tumor is dwindled or reached zero growth, and the state of an illness is controlled.Invalid: clinical symptoms is without being clearly better, and tumor continues to increase.
3.2 treatment statistical result sees Table 1.
Table 1 liang group curative effect relatively
| Group | n | Recovery from illness | Take a turn for the better | Invalid | Total effective rate (%) | The untoward reaction example |
| Treatment group | 100 | 5（5%） | 88（88%) | 7(7%) | 93% | 3 |
| Blank group | 50 | 0（0%） | 5（10%） | 45（90%） | 10% | 0 |
As seen, the medicine that makes of the present invention can safe and effectively be controlled the abdominal cavity malignant tumor.
The specific embodiment
In order to understand better and to implement the present invention, further specify the present invention below in conjunction with specific embodiment.
Specific embodiment 1
Take by weighing: Rhizoma Corydalis 10 grams, Semen Strychni (processed) 21 grams, Herba Asari 9 grams, Herba Hedyotidis Diffusae 25 grams, Radix Scutellariae 10 grams, the Radix Aucklandiae 10 grams, the Radix Angelicae Dahuricae 10 grams, the Radix Linderae 15 grams, Scorpio 10 grams, Borneolum Syntheticum 9 grams, Radix Aconiti Kusnezoffii Preparata 16 grams, Gekko Swinhonis 10 grams, Scolopendra 7 grams, Olibanum (processed) 10 grams, Myrrha (processed) 10 grams, Herba Scutellariae Barbatae 16 grams, Radix Aconiti Preparata 10 grams, Radix Actinidiae Chinensis 15 grams.
An amount of vinegar of the last adding of levigation and Mel reconcile into cream altogether, namely get the unguentum that meets one day consumption of normal adult.Be used for the treatment of the abdominal cavity malignant tumor, spread on the belly place outward, available gauze twines and wraps for the purpose of making things convenient for for taking action, and once a day, keeps more than 16 hours at every turn.
This prescription toxicity is larger, can only be used for external application, absorb by skin, reach tumor suppression dispersing tumor eliminating stagnation with the purpose of pain relieving, can not be oral, be used for clinically the transfer of oophoroma abdominal cavity, advanced liver cancer, advanced colorectal cancer, late gastric cancer, advanced pancreatic cancer etc. ease the pain, and alleviate abdominal distention, improve clinical symptoms, improving life quality all has good curative effect, and couple of days fast after patient's external just can be seen clinical effectiveness, in the situation of skin of abdomen conditions permit, can be interrupted and use half a year, try to be subject to during clinical patient's extensive approval.
Claims (1)
1. external application Chinese medicine for the treatment of the abdominal cavity malignant tumor, it is characterized in that, be prepared from by the medical material of following weight proportion: 10 parts of Rhizoma Corydalis, 21 parts of Semen Strychni (processed)s, 9 parts of Herba Asaris, 25 parts of Herba Hedyotidis Diffusaes, 10 parts of Radix Scutellariaes, 10 parts of the Radix Aucklandiae, 10 parts of the Radixs Angelicae Dahuricae, 15 parts of the Radixs Linderae, 10 parts of Scorpios, 9 parts of Borneolum Syntheticums, 16 parts of Radix Aconiti Kusnezoffii Preparatas, 10 parts of Gekko Swinhonis, 7 parts of Scolopendras, 10 parts of Olibanum (processed)s, 10 parts of Myrrha (processed)s, 16 parts of Herba Scutellariae Barbataes, 10 parts of Radix Aconiti Preparatas, 15 parts of Radix Actinidiae Chinensis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310036743.XA CN103054981B (en) | 2013-01-31 | 2013-01-31 | External traditional Chinese medicine for treating abdominal malignant tumours |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310036743.XA CN103054981B (en) | 2013-01-31 | 2013-01-31 | External traditional Chinese medicine for treating abdominal malignant tumours |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103054981A true CN103054981A (en) | 2013-04-24 |
| CN103054981B CN103054981B (en) | 2014-02-05 |
Family
ID=48098076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310036743.XA Expired - Fee Related CN103054981B (en) | 2013-01-31 | 2013-01-31 | External traditional Chinese medicine for treating abdominal malignant tumours |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103054981B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943967A (en) * | 2016-06-20 | 2016-09-21 | 原巍俊 | Long-noded pit viper containing traditional Chinese medicine composition with effects of clearing dampness and resisting tumors and preparation method thereof |
| CN111110785A (en) * | 2018-11-01 | 2020-05-08 | 北京中西联盟肿瘤医学研究院(普通合伙) | Carbuncle block eliminating ointment for treating cancer pain and preparation method thereof |
| CN112386656A (en) * | 2020-12-15 | 2021-02-23 | 苏宏淼 | Tumor-eliminating pain-relieving ointment and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1108131A (en) * | 1995-01-17 | 1995-09-13 | 李勤 | Magnetic medicinal plaster for assuaging pain of person suffering from cancer |
| CN1413659A (en) * | 2002-10-17 | 2003-04-30 | 王长奎 | Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method |
| US20040105902A1 (en) * | 2002-12-02 | 2004-06-03 | Jiafang Chen | Compositions and methods for treating prostate cancer |
| US20100069824A1 (en) * | 2008-09-18 | 2010-03-18 | Yoshiharu Okamoto | Photodynamic hyperthermic chemotherapy of cancer and therapeutic system therefor |
-
2013
- 2013-01-31 CN CN201310036743.XA patent/CN103054981B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1108131A (en) * | 1995-01-17 | 1995-09-13 | 李勤 | Magnetic medicinal plaster for assuaging pain of person suffering from cancer |
| CN1413659A (en) * | 2002-10-17 | 2003-04-30 | 王长奎 | Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method |
| US20040105902A1 (en) * | 2002-12-02 | 2004-06-03 | Jiafang Chen | Compositions and methods for treating prostate cancer |
| US20100069824A1 (en) * | 2008-09-18 | 2010-03-18 | Yoshiharu Okamoto | Photodynamic hyperthermic chemotherapy of cancer and therapeutic system therefor |
Non-Patent Citations (1)
| Title |
|---|
| 何秀兰等: "《王沛肿瘤治验》", 31 March 2012, article "癌性疼痛的治疗" * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105943967A (en) * | 2016-06-20 | 2016-09-21 | 原巍俊 | Long-noded pit viper containing traditional Chinese medicine composition with effects of clearing dampness and resisting tumors and preparation method thereof |
| CN111110785A (en) * | 2018-11-01 | 2020-05-08 | 北京中西联盟肿瘤医学研究院(普通合伙) | Carbuncle block eliminating ointment for treating cancer pain and preparation method thereof |
| CN112386656A (en) * | 2020-12-15 | 2021-02-23 | 苏宏淼 | Tumor-eliminating pain-relieving ointment and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103054981B (en) | 2014-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102614422B (en) | Traditional Chinese medical decoction for treatment of acute gouty arthritis | |
| CN105477595A (en) | Traditional Chinese medicinal preparation for treating chilblain | |
| CN103054981B (en) | External traditional Chinese medicine for treating abdominal malignant tumours | |
| CN104623331A (en) | Traditional Chinese medicine preparation for treating migraine | |
| CN102240302B (en) | Chinese medicine composition of super gene active peptide | |
| CN104288255A (en) | Traditional Chinese medicine preparation for treating severe acute pancreatitis | |
| CN101439149B (en) | Chinese medicinal composition for treating gastric ulcer, gastrorrhagia and gastric perforation | |
| CN103845617A (en) | Medicament for treating latent glomerulonephritis | |
| CN104147269A (en) | Traditional Chinese medicine used for treating systemic lupus erythematosus | |
| CN103622994A (en) | Compound ointment containing borneol, sulfur and realgar | |
| CN101357206A (en) | Medicine for treating liver cancer and preparation method thereof | |
| CN102488804B (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101904932A (en) | External application Chinese ointment for preventing and curing skin injury caused by ionizing radiation | |
| CN105687672A (en) | Traditional Chinese medicine composition for treating mastitis and mammary gland hyperplasia and preparation method thereof | |
| CN106581241A (en) | Burn and scald treating traditional Chinese medicine composition | |
| CN103933408A (en) | Traditional Chinese medicinal decoction for treating acute gouty arthritis | |
| CN103933481A (en) | External medicine for treating cancer pain and preparation method thereof | |
| CN102772763B (en) | Traditional Chinese medicinal composition for resisting tumor metastasis and method for preparing traditional Chinese medicinal composition | |
| CN103285224B (en) | Traditional Chinese medicine for treating lymphoid tuberculosis | |
| CN102973668A (en) | Compound pure traditional Chinese medicine composition for treating avian infectious laryngotracheitis and preparation method thereof | |
| CN103800506A (en) | Traditional Chinese medicine composition for treating infantile parotitis and preparation method thereof | |
| CN105055665A (en) | Anti-hepatoma traditional Chinese medicine preparation | |
| CN105561213A (en) | External application traditional Chinese medicine used for acute gouty arthritis | |
| CN103610887B (en) | A kind of Chinese medicine for the treatment of necrotizing fasciitis | |
| CN103479917B (en) | Traditional Chinese medicine composition for treating burns and scalds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140205 Termination date: 20180131 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |